questionsmedicales.fr
Cellules
Cellules cultivées
Cellules cancéreuses en culture
Lignée cellulaire tumorale
Cellules THP-1
Cellules THP-1 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Cell-Derived Microparticles
Diagnostic
5
Lignées cellulaires
Monocytes
Cytométrie en flux
Immunofluorescence
Contamination cellulaire
Mycoplasmes
Sensibilité aux médicaments
Pharmacologie
Symptômes
5
Marqueurs cellulaires
Activation cellulaire
Différenciation cellulaire
Macrophages
Prévention
5
Prévention de la contamination
Techniques aseptiques
Conditions de culture
Milieu de culture
Soins cellulaires
Stress cellulaire
Viabilité cellulaire
Congélation
Cryogénisation
Conservation cellulaire
Traitements
5
Recherche biomédicale
Médicaments
Modification génétique
CRISPR
Traitements anti-inflammatoires
Anticancéreux
Toxicité
Composés chimiques
Modélisation des maladies
Maladies inflammatoires
Complications
5
Complications expérimentales
Biais
Réponses immunitaires
Immunité
Risques de laboratoire
Contamination croisée
Agents externes
Fonction cellulaire
Minimisation des risques
Contrôles de qualité
Facteurs de risque
5
Facteurs de croissance
Milieu de culture
Agents environnementaux
Sensibilité cellulaire
Stress oxydatif
Viabilité cellulaire
Facteurs génétiques
Réponse immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cellules THP-1 : Questions médicales les plus fréquentes",
"headline": "Cellules THP-1 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cellules THP-1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-26",
"dateModified": "2025-03-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cellules THP-1"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lignée cellulaire tumorale",
"url": "https://questionsmedicales.fr/mesh/D045744",
"about": {
"@type": "MedicalCondition",
"name": "Lignée cellulaire tumorale",
"code": {
"@type": "MedicalCode",
"code": "D045744",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.251.860.180"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Cellules THP-1",
"alternateName": "THP-1 Cells",
"code": {
"@type": "MedicalCode",
"code": "D000074084",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Terumasa Ikeda",
"url": "https://questionsmedicales.fr/author/Terumasa%20Ikeda",
"affiliation": {
"@type": "Organization",
"name": "2 Institute for Molecular Virology, Minneapolis, MN 55455, USA."
}
},
{
"@type": "Person",
"name": "Michael A Carpenter",
"url": "https://questionsmedicales.fr/author/Michael%20A%20Carpenter",
"affiliation": {
"@type": "Organization",
"name": "3 Center for Genome Engineering, Minneapolis, MN 55455, USA."
}
},
{
"@type": "Person",
"name": "William L Brown",
"url": "https://questionsmedicales.fr/author/William%20L%20Brown",
"affiliation": {
"@type": "Organization",
"name": "4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA."
}
},
{
"@type": "Person",
"name": "Reuben S Harris",
"url": "https://questionsmedicales.fr/author/Reuben%20S%20Harris",
"affiliation": {
"@type": "Organization",
"name": "3 Center for Genome Engineering, Minneapolis, MN 55455, USA."
}
},
{
"@type": "Person",
"name": "Valentina Galbiati",
"url": "https://questionsmedicales.fr/author/Valentina%20Galbiati",
"affiliation": {
"@type": "Organization",
"name": "Università Degli Studi di Milano, Laboratory of Toxicology, Dipartimento di Scienze Politiche ed Ambientali, Milan, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Platelet-Derived Microparticles and Autoimmune Diseases.",
"datePublished": "2023-06-17",
"url": "https://questionsmedicales.fr/article/37373420",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241210275"
}
},
{
"@type": "ScholarlyArticle",
"name": "Red Blood Cell-Derived Microparticles Exert No Cancer Promoting Effects on Colorectal Cancer Cells In Vitro.",
"datePublished": "2022-08-18",
"url": "https://questionsmedicales.fr/article/36012587",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23169323"
}
},
{
"@type": "ScholarlyArticle",
"name": "Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36732759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12951-023-01792-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hydrophobicity-Adaptive Polymers Trigger Fission of Tumor-Cell-Derived Microparticles for Enhanced Anticancer Drug Delivery.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37755231",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/adma.202211980"
}
},
{
"@type": "ScholarlyArticle",
"name": "Urinary red blood cell-derived microparticles and phosphatidylserine-exposing red blood cells in glomerular and non-glomerular hematuria patients.",
"datePublished": "2022-06-15",
"url": "https://questionsmedicales.fr/article/35703591",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cyto.b.22083"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Cellules cultivées",
"item": "https://questionsmedicales.fr/mesh/D002478"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cellules cancéreuses en culture",
"item": "https://questionsmedicales.fr/mesh/D014407"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lignée cellulaire tumorale",
"item": "https://questionsmedicales.fr/mesh/D045744"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cellules THP-1",
"item": "https://questionsmedicales.fr/mesh/D000074084"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cellules THP-1 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cellules THP-1",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cellules THP-1",
"description": "Comment identifier les cellules THP-1 en laboratoire ?\nQuels tests sont utilisés pour caractériser les cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être contaminées ?\nQuelle est la source des cellules THP-1 ?\nLes cellules THP-1 sont-elles sensibles à des médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Cell-Derived+Microparticles#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cellules THP-1",
"description": "Quels sont les marqueurs d'activation des cellules THP-1 ?\nLes cellules THP-1 montrent-elles des signes d'inflammation ?\nComment les cellules THP-1 réagissent-elles aux pathogènes ?\nLes cellules THP-1 peuvent-elles se différencier ?\nQuels effets ont les cytokines sur les cellules THP-1 ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Cell-Derived+Microparticles#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cellules THP-1",
"description": "Comment prévenir la contamination des cellules THP-1 ?\nQuelles conditions de culture sont idéales pour les cellules THP-1 ?\nLes cellules THP-1 nécessitent-elles des soins particuliers ?\nComment assurer la viabilité des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être cryogénisées ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Cell-Derived+Microparticles#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cellules THP-1",
"description": "Comment les cellules THP-1 sont-elles utilisées en recherche ?\nPeut-on modifier génétiquement les cellules THP-1 ?\nQuels traitements sont testés sur les cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être utilisées pour des tests de toxicité ?\nComment les cellules THP-1 aident-elles à comprendre les maladies ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Cell-Derived+Microparticles#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cellules THP-1",
"description": "Quelles complications peuvent survenir lors de l'utilisation des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles induire des réponses immunitaires indésirables ?\nQuels risques sont associés à la manipulation des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être affectées par des agents externes ?\nComment minimiser les complications lors des expériences avec THP-1 ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Cell-Derived+Microparticles#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cellules THP-1",
"description": "Quels facteurs influencent la croissance des cellules THP-1 ?\nLes cellules THP-1 sont-elles sensibles à des agents environnementaux ?\nQuels traitements peuvent affecter les cellules THP-1 ?\nLes cellules THP-1 sont-elles affectées par le stress oxydatif ?\nQuels facteurs génétiques influencent les cellules THP-1 ?",
"url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Cell-Derived+Microparticles#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les cellules THP-1 en laboratoire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cellules THP-1 sont identifiées par leur morphologie et leur expression de marqueurs spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour caractériser les cellules THP-1 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la cytométrie en flux et l'immunofluorescence sont utilisés."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles être contaminées ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comme toutes les lignées cellulaires, elles peuvent être contaminées par des bactéries ou des mycoplasmes."
}
},
{
"@type": "Question",
"name": "Quelle est la source des cellules THP-1 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cellules THP-1 proviennent de la moelle osseuse d'un patient atteint de leucémie."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 sont-elles sensibles à des médicaments ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent utilisées pour tester la sensibilité à divers agents pharmacologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les marqueurs d'activation des cellules THP-1 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs incluent CD14, CD11b et CD68, indiquant leur activation."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 montrent-elles des signes d'inflammation ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles produisent des cytokines pro-inflammatoires lorsqu'elles sont activées."
}
},
{
"@type": "Question",
"name": "Comment les cellules THP-1 réagissent-elles aux pathogènes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles phagocytent les pathogènes et sécrètent des médiateurs inflammatoires."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles se différencier ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent se différencier en macrophages sous l'influence de certains facteurs."
}
},
{
"@type": "Question",
"name": "Quels effets ont les cytokines sur les cellules THP-1 ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cytokines modulent leur activation et leur capacité à produire d'autres médiateurs."
}
},
{
"@type": "Question",
"name": "Comment prévenir la contamination des cellules THP-1 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des techniques aseptiques et vérifier régulièrement la pureté cellulaire."
}
},
{
"@type": "Question",
"name": "Quelles conditions de culture sont idéales pour les cellules THP-1 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles nécessitent un milieu riche en nutriments et une température contrôlée."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 nécessitent-elles des soins particuliers ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent être manipulées avec précaution pour éviter le stress cellulaire."
}
},
{
"@type": "Question",
"name": "Comment assurer la viabilité des cellules THP-1 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir des conditions optimales de culture et éviter les cycles de congélation-décongélation."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles être cryogénisées ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être cryogénisées pour une conservation à long terme."
}
},
{
"@type": "Question",
"name": "Comment les cellules THP-1 sont-elles utilisées en recherche ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont utilisées pour étudier les mécanismes immunitaires et tester des médicaments."
}
},
{
"@type": "Question",
"name": "Peut-on modifier génétiquement les cellules THP-1 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme CRISPR peuvent être utilisées pour modifier leur génome."
}
},
{
"@type": "Question",
"name": "Quels traitements sont testés sur les cellules THP-1 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements anti-inflammatoires et anticancéreux sont souvent testés."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles être utilisées pour des tests de toxicité ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent utilisées pour évaluer la toxicité des composés chimiques."
}
},
{
"@type": "Question",
"name": "Comment les cellules THP-1 aident-elles à comprendre les maladies ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles modélisent des maladies inflammatoires et infectieuses pour étudier les mécanismes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir lors de l'utilisation des cellules THP-1 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des résultats biaisés peuvent survenir si les cellules sont contaminées ou mal caractérisées."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles induire des réponses immunitaires indésirables ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent parfois produire des réponses immunitaires non spécifiques."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à la manipulation des cellules THP-1 ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque principal est la contamination croisée avec d'autres lignées cellulaires."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 peuvent-elles être affectées par des agents externes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des agents comme les toxines ou les médicaments peuvent altérer leur fonction."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications lors des expériences avec THP-1 ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre des protocoles stricts et effectuer des contrôles réguliers de qualité."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent la croissance des cellules THP-1 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme la température, le pH et la composition du milieu influencent leur croissance."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 sont-elles sensibles à des agents environnementaux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être affectées par des agents chimiques ou physiques dans leur environnement."
}
},
{
"@type": "Question",
"name": "Quels traitements peuvent affecter les cellules THP-1 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme les cytokines ou les médicaments peuvent moduler leur activité."
}
},
{
"@type": "Question",
"name": "Les cellules THP-1 sont-elles affectées par le stress oxydatif ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut altérer leur fonction et leur viabilité."
}
},
{
"@type": "Question",
"name": "Quels facteurs génétiques influencent les cellules THP-1 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des variations génétiques peuvent affecter leur réponse aux stimuli immunitaires."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
2 Institute for Molecular Virology, Minneapolis, MN 55455, USA.
3 Center for Genome Engineering, Minneapolis, MN 55455, USA.
5 Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN 55455, USA.
1 Department of Biochemistry, Molecular Biology, and Biophysics, Minneapolis, MN 55455, USA.
4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Publications dans "Cellules THP-1" :
3 publications dans cette catégorie
Affiliations :
3 Center for Genome Engineering, Minneapolis, MN 55455, USA.
1 Department of Biochemistry, Molecular Biology, and Biophysics, Minneapolis, MN 55455, USA.
4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
2 Institute for Molecular Virology, Minneapolis, MN 55455, USA.
5 Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN 55455, USA.
Publications dans "Cellules THP-1" :
3 publications dans cette catégorie
Affiliations :
4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
3 Center for Genome Engineering, Minneapolis, MN 55455, USA.
2 Institute for Molecular Virology, Minneapolis, MN 55455, USA.
1 Department of Biochemistry, Molecular Biology, and Biophysics, Minneapolis, MN 55455, USA.
Publications dans "Cellules THP-1" :
3 publications dans cette catégorie
Affiliations :
3 Center for Genome Engineering, Minneapolis, MN 55455, USA.
1 Department of Biochemistry, Molecular Biology, and Biophysics, Minneapolis, MN 55455, USA.
4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
2 Institute for Molecular Virology, Minneapolis, MN 55455, USA.
5 Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN 55455, USA.
Publications dans "Cellules THP-1" :
3 publications dans cette catégorie
Affiliations :
Università Degli Studi di Milano, Laboratory of Toxicology, Dipartimento di Scienze Politiche ed Ambientali, Milan, Italy.
Publications dans "Cellules THP-1" :
3 publications dans cette catégorie
Affiliations :
Università Degli Studi di Milano, Laboratory of Toxicology, Dipartimento di Scienze Politiche ed Ambientali, Milan, Italy.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of The Ministry of Education for Conservation and Utilization of Special Biological Resources in The West, Yinchuan, Ningxia 750021, P.R. China.
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, P.R. China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of The Ministry of Education for Conservation and Utilization of Special Biological Resources in The West, Yinchuan, Ningxia 750021, P.R. China.
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, P.R. China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of The Ministry of Education for Conservation and Utilization of Special Biological Resources in The West, Yinchuan, Ningxia 750021, P.R. China.
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, P.R. China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of The Ministry of Education for Conservation and Utilization of Special Biological Resources in The West, Yinchuan, Ningxia 750021, P.R. China.
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, P.R. China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of The Ministry of Education for Conservation and Utilization of Special Biological Resources in The West, Yinchuan, Ningxia 750021, P.R. China.
College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, P.R. China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Cheeloo College of Medicine, Shandong University Ji'nan 250012, China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Università Degli Studi di Pavia, Dipartimento di Scienze del Farmaco, Pavia, Italy.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Università Degli Studi di Pavia, Dipartimento di Scienze del Farmaco, Pavia, Italy.
Scuola Universitaria Superiore IUSS, Pavia, Italy.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Università Degli Studi di Pavia, Dipartimento di Scienze del Farmaco, Pavia, Italy.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Università Degli Studi di Pavia, Dipartimento di Scienze del Farmaco, Pavia, Italy.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, West China School of Medicine/West China Hospital, Sichuan University, Chengdu, China, 3341148215@qq.com.
Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Publications dans "Cellules THP-1" :
2 publications dans cette catégorie
Affiliations :
Shandong Provincial Key Laboratory of Animal Resistance Biology, Institute of Biomedical Sciences, College of Life Sciences, Shandong Normal University, Jinan, Shandong 250014, P.R. China.
Publications dans "Cellules THP-1" :
Extracellular microparticles provide a means of cell-to-cell communication and can promote information exchanges between adjacent or distant cells. Platelets are cell fragments that are derived from m...
The biomedical consequences of allogeneic blood transfusions and the possible pathomechanisms of transfusion-related morbidity and mortality are still not entirely understood. In retrospective studies...
Cancer stem cells (CSCs) are crucial for the growth, metastasis, drug resistance, recurrence, and spread of tumors. Napabucasin (NAP) could effectively inhibit CSC, but its mechanism has not been full...
The study discovered a new mechanism for NAP inhibiting tumors. NAP, in addition to inhibiting STAT3, may also inhibit STAT1, thereby inhibiting the expression of CD44, and the stemness of colon cance...
As a combined diagnostic and therapeutic nanoprobe, N...
Tumor-cell-derived microparticles (MPs) can function as anticancer drug-delivery carriers. However, short blood circulation time, large-size-induced insufficient tumor accumulation and penetration int...
Distinguishing glomerular hematuria (GH) from non-glomerular hematuria (NGH) is important for treating the cause of hematuria. We aimed to determine red blood cell-derived microparticles (RMPs) and ph...
All patients received a physical assessment and urological examination. Dysmorphic RBCs (dRBCs) and acanthocytes were examined using a light microscope. The urinary RMPs and PS-exposing RBCs were dete...
The ratio of RMPs to RBCs was higher in GH patients (n = 29) than in NGH patients (n = 29) (1.06 vs. 0.18). The value of the sum of the PS-exposing RBCs plus RMPs divided by the number of RBCs was hig...
Patients with GH have higher numbers of urinary RMPs and PS-exposing RBCs. These parameters have the potential to be predictive tools for classifying GH in the future....
Metastasis is the main cause of death in patients with colorectal cancer (CRC). Apart from platelets, platelet-derived microparticles (PMPs) are also considered important factors that can modify the a...
We used various CRC cell lines, including the epithelial-like HT29 and the mesenchymal-like SW480 and SW620. Confocal imaging was applied to study PMP incorporation into CRC cells. The presence of sur...
We found that CRC cells could incorporate PMPs in a time-dependent manner. Moreover, PMPs could transfer platelet-specific integrins and stimulate the expression of integrins already present on tested...
We conclude that PMPs can fuse into both epithelial-like and mesenchymal-like CRC cells and increase their invasive potential by inducing the expression and release of MMP-2 and MMP-9 via the p38MAPK ...
Studies on microparticles (MPs) in patients with antiphospholipid antibodies (aPL) are sparse and inconclusive. The relation between MPs and different aPL antibody profiles has never been tested. We e...
Megamix (Biocytex) was used to set up the MPs gating according to the datasheet. Markers of Platelet Microparticles (PMPs) were CD41a-PE and annexin-V-FITC that was used to determine phosphatidylserin...
The number of total MPs and EMPs was significantly higher in triple positive groups with respect to single positive group and showed a significant correlation with IgG aβ2GPI titers. The number PMPs w...
Elevated levels of total MPs and EMPs suggest a state of vascular activation in IgG aβ2GPI positive individuals according to the number of positive tests. PMPs may be fast cleared from circulation in ...
Triple-negative breast cancer (TNBC) is a highly heterogeneous tumor characterized by high recurrence and metastasis, with a very poor prognosis, and there are still great challenges in its clinical t...
It is well established that inflammation and platelets promote multiple processes of cancer malignancy. Recently, platelets have received attention for their role in carcinogenesis through the product...
CLL cell lines were co-incubated with different concentrations of human PMPs, and their impact on cell proliferation, mitochondrial DNA copy number, OCR level, ATP production, and ROS content was eval...
The data demonstrated the potency of PMPs in inducing tumoral growth and invasiveness in CLLs through mitochondrial internalization and OXPHOS stimulation which was in line with metabolic shift report...
Altogether, these findings depict a new platelet-mediated pathway of cancer pathogenesis. We also highlight the impact of PMPs in CLL metabolic reprogramming and disease progression....
Immune checkpoint blockade (ICB) therapy, particularly antibodies targeting the programmed death receptor 1 (PD-1) and its ligand (PD-L1), has revolutionized cancer treatment. However, its efficacy as...